Managing Immune Checkpoint-Blocking Antibody Side Effects
Immune checkpoint-blocking antibodies that enhance the immune system's ability to fight cancer are becoming important components of treatment for patients with a variety of malignancies. Cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) was the first immune checkpoint to be clinically target...
Saved in:
| Hovedforfatter: | |
|---|---|
| Format: | Revisão |
| Sprog: | engelsk |
| Udgivet: |
2015
|
| Online adgang: | https://doi.org/10.14694/edbook_am.2015.35.76 https://ascopubs.org/doi/pdfdirect/10.14694/EdBook_AM.2015.35.76 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|
Vær først til at give en kommentarø!